Skip to main content

CMS Pulls Unlawful Medicare Part D Rule

In response to a tidal wave of public opposition, HHS’s Centers for Medicare & Medicaid Services informed Congress on Monday that the agency is shelving its proposal to participate in Medicare Part D prescription drug price negotiations. As Boyden Gray explained in a February 26 letter, the proposed rule would have violated the noninterference provision of the Medicare Modernization Act of 2003….

Read More

BG&A Builds Legal Case Against HHS Interference in Drug Pricing Negotiations

On February 24, Boyden Gray & Associates released an opinion letter explaining why the U.S. Department of Health and Human Service’s recent reinterpretation of Medicare Part D’s noninterference provision is unlawful and unsustainable. This letter was cited in the testimony of Douglas Holtz-Eakin, president of the American Action Forum, in a February 26 hearing before the House Energy & Commerce Committee.

Read More